{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:14:29Z","timestamp":1792797269800,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2022\\u201341480-38137"],"award-info":[{"award-number":["2022\\u201341480-38137"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2023\\u201341480-41035"],"award-info":[{"award-number":["2023\\u201341480-41035"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2024\\u201341480-43776"],"award-info":[{"award-number":["2024\\u201341480-43776"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environment International"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.envint.2025.109339","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:05:56Z","timestamp":1739819156000},"page":"109339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Chemical risk assessment in food animals via physiologically based pharmacokinetic modeling \u2212 Part I: Veterinary drugs on human food safety assessment"],"prefix":"10.1016","volume":"197","author":[{"given":"Kun","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoumeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.envint.2025.109339_b0005","article-title":"Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats","volume":"11","author":"Ai","year":"2024","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107547","article-title":"A generic avian physiologically-based kinetic (PBK) model and its application in three bird species","volume":"169","author":"Baier","year":"2022","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2025.109339_b0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fct.2015.12.020","article-title":"Health concerns and management of select veterinary drug residues","volume":"88","author":"Baynes","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0020","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/jps.20073","article-title":"Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination","volume":"93","author":"Berezhkovskiy","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0025","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/psp4.13118","article-title":"Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs","volume":"13","author":"Bettonte","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.envint.2025.109339_b0030","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/10408444.2017.1340259","article-title":"Characterizing chronic and acute health risks of residues of veterinary drugs in food: latest methodological developments by the joint FAO\/WHO expert committee on food additives","volume":"47","author":"Boobis","year":"2017","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0035","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3390\/ani11102878","article-title":"Rational pharmacotherapy in infectious diseases: issues related to drug residues in edible animal tissues","volume":"11","author":"Canton","year":"2021","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.envint.2025.109339_b0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/dta.2024","article-title":"An update discussion on the current assessment of the safety of veterinary antimicrobial drug residues in food with regard to their impact on the human intestinal microbiome","volume":"8","author":"Cerniglia","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.envint.2025.109339_b0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/toxics10050232","article-title":"IVIVE: facilitating the use of in vitro toxicity data in risk assessment and decision making","volume":"10","author":"Chang","year":"2022","journal-title":"Toxics."},{"key":"10.1016\/j.envint.2025.109339_b0050","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1021\/acs.jmedchem.0c02033","article-title":"Model-based target pharmacology assessment (mTPA): An approach using PBPK\/PD modeling and machine learning to design medicinal chemistry and DMPK strategies in early drug discovery","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.envint.2025.109339_b0055","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1021\/acs.est.1c06479","article-title":"Integration of toxicogenomics and physiologically based pharmacokinetic modeling in human health risk assessment of perfluorooctane sulfonate","volume":"56","author":"Chen","year":"2022","journal-title":"Environ. Sci. Tech."},{"key":"10.1016\/j.envint.2025.109339_b0060","doi-asserted-by":"crossref","first-page":"e1808","DOI":"10.1002\/wnan.1808","article-title":"Toxicokinetics, dose\u2013response, and risk assessment of nanomaterials: methodology, challenges, and future perspectives","volume":"14","author":"Chen","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.envint.2025.109339_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104806","article-title":"Assessment of veterinary drug residues in food: Considerations when dealing with sub-optimal data","volume":"118","author":"Chicoine","year":"2020","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.envint.2025.109339_b0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.taap.2009.07.032","article-title":"Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach","volume":"241","author":"Chiu","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.envint.2025.109339_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11882-002-0033-y","article-title":"Allergic adverse reactions to sulfonamides","volume":"2","author":"Choquet-Kastylevsky","year":"2002","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.envint.2025.109339_b0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12989-022-00489-4","article-title":"Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats","volume":"19","author":"Chou","year":"2022","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0085","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.envint.2019.03.058","article-title":"Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: development and performance verification","volume":"129","author":"Chou","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2025.109339_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.114062","volume":"181","author":"Chou","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0095","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/toxsci\/kfac056","article-title":"An interactive generic physiologically based pharmacokinetic (igPBPK) Modeling platform to predict drug withdrawal intervals in cattle and swine: a case study on flunixin, florfenicol, and penicillin G","volume":"188","author":"Chou","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.envint.2019.03.003","article-title":"Membrane transporter data to support kinetically-informed chemical risk assessment using non-animal methods: scientific and regulatory perspectives","volume":"126","author":"Clerbaux","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2025.109339_b0105","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/s41467-024-45563-x","article-title":"Structured information extraction from scientific text with large language models","volume":"15","author":"Dagdelen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envint.2025.109339_b0110","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.3390\/ijerph20043473","article-title":"The role of \u201cphysiologically based pharmacokinetic model (PBPK)\u201d new approach methodology (NAM) in pharmaceuticals and environmental chemical risk assessment","volume":"20","author":"Deepika","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.envint.2025.109339_b0115","doi-asserted-by":"crossref","DOI":"10.2903\/j.efsa.2023.e211101","article-title":"TKPlate 1.0: An Open-access platform for toxicokinetic and toxicodynamic modelling of chemicals to implement new approach methodologies in chemical risk assessment","volume":"21","author":"Dorne","year":"2023","journal-title":"EFSA J."},{"key":"10.1016\/j.envint.2025.109339_b0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.taap.2012.03.013","article-title":"Human and animal health risk assessments of chemicals in the food chain: comparative aspects and future perspectives","volume":"270","author":"Dorne","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.envint.2025.109339_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116495","article-title":"Systematic review of physiologically based kinetic lactation models for transfer of xenobiotic compounds to milk","volume":"467","author":"Dubbelboer","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.envint.2025.109339_b0130","first-page":"3638","article-title":"Modern methodologies and tools for human hazard assessment of chemicals","volume":"12","author":"EFSA","year":"2014","journal-title":"EFSA J."},{"key":"10.1016\/j.envint.2025.109339_b0135","first-page":"3589","article-title":"Scientific Opinion on good modelling practice in the context of mechanistic effect models for risk assessment of plant protection products","volume":"12","author":"EFSA","year":"2014","journal-title":"EFSA J."},{"key":"10.1016\/j.envint.2025.109339_b0140","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jac\/dku530","article-title":"Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"Eliakim-Raz","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.envint.2025.109339_b0145","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1080\/00498254.2020.1763513","article-title":"Proteomic characterisation of drug metabolising enzymes and drug transporters in pig liver","volume":"50","author":"Elmorsi","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.envint.2025.109339_b0150","unstructured":"EMA, 2016. Guideline on Approach towards Harmonisation of Withdrawal Periods. European Medicines Agency, London, UK. Available: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-approach-towards-harmonisation-withdrawal-periods_en.pdf. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0155","unstructured":"EMA, 2018. Guideline on the reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation. European Medicines Agency, London, UK. Available: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-reporting-physiologically-based-pharmacokinetic-pbpk-modelling-and-simulation_en.pdf. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0160","unstructured":"EPA, 2006. Approaches For the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data In Risk Assessment (Final Report). Environmental Protection Agency, Washington, D.C. Available: https:\/\/cfpub.epa.gov\/si\/si_public_record_Report.cfm?Lab=NCEA&dirEntryID=157668. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0165","unstructured":"EPA, 2025. Human Health Risk Assessment. Environmental Protection Agency, U.S. Available: https:\/\/www.epa.gov\/risk\/human-health-risk-assessment. (accessed 22 January 2025)."},{"key":"10.1016\/j.envint.2025.109339_b0170","unstructured":"FDA, 2016. CVM Guidance for Industry (GFI)# 3: General principles for evaluating the human food safety of new animal drugs used in food-producing animals. US Food and Drug Administration. Available: https:\/\/www.fda.gov\/media\/70028\/download. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0175","unstructured":"FDA, 2018. Physiologically based pharmacokinetic analyses-format and content guidance for industry. US Food and Drug Administration. Available: https:\/\/www.fda.gov\/media\/101469\/download. (accessed 26 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114789","article-title":"Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)","volume":"190","author":"Gonnabathula","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0185","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.scitotenv.2018.09.163","article-title":"Generic physiologically-based toxicokinetic modelling for fish: integration of environmental factors and species variability","volume":"651","author":"Grech","year":"2019","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.envint.2025.109339_b0190","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/00071668.2011.577055","article-title":"Kinetic modelling and residue depletion of drugs in eggs","volume":"52","author":"Hekman","year":"2011","journal-title":"Br. Poult. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0195","article-title":"Modelling shows the negative impact of age dependent pharmacokinetics on the efficacy of oxytetracycline in young steers","volume":"8","author":"Hekman","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0200","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1021\/es048442o","article-title":"Critical body residues linked to octanol-water partitioning, organism composition, and LC50 QSARs: meta-analysis and model","volume":"39","author":"Hendriks","year":"2005","journal-title":"Environ. Sci. Tech."},{"key":"10.1016\/j.envint.2025.109339_b0205","first-page":"2002","article-title":"Estimation of residue depletion of cyadox and its marker residue in edible tissues of pigs using physiologically based pharmacokinetic modelling","volume":"32","author":"Huang","year":"2015","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess."},{"key":"10.1016\/j.envint.2025.109339_b0210","unstructured":"JECFA, 2017. Guidance document for the establishment of Acute Reference Dose (ARfD) for veterinary drug residues in food. Joint FAO\/WHO Expert Committee on Food Additives (JECFA), Switzerland. Available: https:\/\/www.who.int\/publications\/i\/item\/9789241512626 (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0215","unstructured":"JECFA, 2020. Principles and methods for the risk assessment of chemicals in food. Joint FAO\/WHO Expert Committee on Food Additives (JECFA), Switzerland. Available: https:\/\/www.who.int\/publications\/i\/item\/9789241572408. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0220","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2460\/javma.2005.227.1574","article-title":"Effect of formulation and route of administration on tissue residues and withdrawal times","volume":"227","author":"KuKanich","year":"2005","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.envint.2025.109339_b0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.toxlet.2019.10.021","article-title":"Generic physiologically based kinetic modelling for farm animals: Part I. Data collection of physiological parameters in swine, cattle and sheep","volume":"319","author":"Lautz","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.envint.2025.109339_b0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.toxlet.2024.06.012","article-title":"Application of partition coefficient methods to predict tissue:plasma affinities in common farm animals: Influence of ionisation state","volume":"398","author":"Lautz","year":"2024","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.envint.2025.109339_b0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.toxlet.2019.10.008","article-title":"Generic physiologically based kinetic modelling for farm animals: Part II. Predicting tissue concentrations of chemicals in swine, cattle, and sheep","volume":"318","author":"Lautz","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.envint.2025.109339_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114812","article-title":"Application of a generic PBK model for beef cattle: Tissue\/fluid correlations of paracetamol and NSAIDs","volume":"190","author":"Lautz","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105488","article-title":"An open source physiologically based kinetic model for the chicken (Gallus gallus domesticus): Calibration and validation for the prediction residues in tissues and eggs","volume":"136","author":"Lautz","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2025.109339_b0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tiv.2019.05.002","article-title":"Physiologically based kinetic models for farm animals: critical review of published models and future perspectives for their use in chemical risk assessment","volume":"60","author":"Lautz","year":"2019","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.envint.2025.109339_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113086","article-title":"Fipronil and fipronil sulfone in chicken: from in vitro experiments to in vivo PBK model predictions","volume":"165","author":"Lautz","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2885.2011.01304.x","article-title":"Development of a physiologically based pharmacokinetic model to predict tulathromycin distribution in goats","volume":"35","author":"Leavens","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0265","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00204-019-02464-z","volume":"93","author":"Li","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.fct.2017.06.023","article-title":"Development and application of a population physiologically based pharmacokinetic model for penicillin G in swine and cattle for food safety assessment","volume":"107","author":"Li","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/toxsci\/kfy067","article-title":"Probabilistic physiologically based pharmacokinetic model for penicillin G in milk from dairy cows following intramammary or intramuscular administrations","volume":"164","author":"Li","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0280","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jvp.12766","article-title":"An integrated experimental and physiologically based pharmacokinetic modeling study of penicillin G in heavy sows","volume":"42","author":"Li","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0285","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/jvp.12938","article-title":"Physiological parameter values for physiologically based pharmacokinetic models in food-producing animals. Part III: Sheep and goat","volume":"44","author":"Li","year":"2021","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.111867","article-title":"Bayesian population physiologically-based pharmacokinetic model for robustness evaluation of withdrawal time in tilapia aquaculture administrated to florfenicol","volume":"210","author":"Lin","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.envint.2025.109339_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114809","volume":"190","author":"Lin","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0300","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/jvp.12311","article-title":"Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment","volume":"39","author":"Lin","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/kfx070","article-title":"Performance assessment and translation of physiologically based pharmacokinetic models from acslX to Berkeley Madonna, MATLAB, and R language: oxytetracycline and gold nanoparticles as case examples","volume":"158","author":"Lin","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0310","unstructured":"Lin, Z.,Li, M.,Baynes, R.,Tell, L.,Davis, J.,Vickroy, T.,Riviere, J. Development and application of an interactive physiologically based pharmacokinetic (iPBPK) model interface to estimate withdrawal intervals for penicillin G in cattle and swine. The 59th Annual Meeting of Society of Toxicology, Anaheim, California. The toxicologist, Supplement to Toxicological Sciences; 2020a."},{"key":"10.1016\/j.envint.2025.109339_b0315","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jps.24244","article-title":"Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans","volume":"104","author":"Lin","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/jvp.12861","article-title":"Physiological parameter values for physiologically based pharmacokinetic models in food-producing animals. Part I: Cattle and swine","volume":"43","author":"Lin","year":"2020","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0325","doi-asserted-by":"crossref","first-page":"27907","DOI":"10.1038\/srep27907","article-title":"Human food safety implications of variation in food animal drug metabolism","volume":"6","author":"Lin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envint.2025.109339_b0330","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0278-6915(89)90032-X","article-title":"Chronic toxicity\/carcinogenicity studies of sulphamethazine in B6C3F1 mice","volume":"27","author":"Littlefield","year":"1989","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2022.120290","article-title":"Enhanced prediction of internal concentrations of phenolic endocrine disrupting chemicals and their metabolites in fish by a physiologically based toxicokinetic incorporating metabolism (PBTK-MT) model","volume":"314","author":"Liu","year":"2022","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.envint.2025.109339_b0340","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1260260","article-title":"Science and regulation. One Health approach to use of veterinary pharmaceuticals","volume":"346","author":"Margalida","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.envint.2025.109339_b0345","doi-asserted-by":"crossref","unstructured":"Mi, K.,Lin, Z., 2025. Chemical risk assessment in food animals via physiologically based pharmacokinetic modeling - Part II: environmental pollutants on animal and human health assessments. under review.","DOI":"10.1016\/j.envint.2025.109372"},{"key":"10.1016\/j.envint.2025.109339_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011331","article-title":"A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs","volume":"19","author":"Mi","year":"2023","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.envint.2025.109339_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1378034","article-title":"A physiologically based pharmacokinetic\/pharmacodynamic model to determine dosage regimens and withdrawal intervals of aditoprim against Streptococcus suis","volume":"15","author":"Mi","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.envint.2025.109339_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquatox.2022.106174","article-title":"The toxicokinetics of bisphenol A and its metabolites in fish elucidated by a PBTK model","volume":"247","author":"Mit","year":"2022","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0365","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1007\/s00204-022-03356-5","article-title":"Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment","volume":"96","author":"Najjar","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117343","article-title":"IVIVE-PBPK based new approach methodology for addressing early life toxicity induced by Bisphenol A","volume":"240","author":"Ni","year":"2024","journal-title":"Environ. Res."},{"key":"10.1016\/j.envint.2025.109339_b0375","unstructured":"OECD, 2021. Characterisation, validation and reporting of Physiologically Based Kinetic (PBK) models for regulatory purposes. Organisation for Economic Co-operation and Development, Paris,France. Available: https:\/\/www.oecd.org\/chemicalsafety\/risk-assessment\/guidance-document-on-the-characterisation-validation-and-reporting-of-physiologically-based-kinetic-models-for-regulatory-purposes.pdf. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0380","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41467-024-45914-8","article-title":"Extracting accurate materials data from research papers with conversational language models and prompt engineering","volume":"15","author":"Polak","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envint.2025.109339_b0385","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jps.10005","article-title":"Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution","volume":"91","author":"Poulin","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0390","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/toxsci\/kfab150","article-title":"Predictive performance of next generation physiologically based kinetic (PBK) model predictions in rats based on in vitro and in silico input data","volume":"186","author":"Punt","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0395","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/acs.chemrestox.0c00307","article-title":"Development of a web-based toolbox to support quantitative in-vitro-to-in-vivo extrapolations (QIVIVE) within nonanimal testing strategies","volume":"34","author":"Punt","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0400","doi-asserted-by":"crossref","unstructured":"Reale, E., Zare Jeddi, M., Paini, A., Connolly, A., Duca, R., Cubadda, F., Benfenati, E., Bessems, J.,K, S.G.,Dirven, H., Santonen, T.,H, M.K., Jones, K.,Sams, C., Viegas, S.,Kyriaki, M., Campisi, L., David, A., Antignac, J.P.,N, B.H., 2024. Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment. Environ Int. 184, 108474. https:\/\/doi.org\/10.1016\/j.envint.2024.108474.","DOI":"10.1016\/j.envint.2024.108474"},{"key":"10.1016\/j.envint.2025.109339_b0405","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/toxsci\/kfab095","article-title":"Development and application of an interactive physiologically based pharmacokinetic (iPBPK) model to predict oxytetracycline tissue distribution and withdrawal intervals in market-age sheep and goats","volume":"183","author":"Riad","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0410","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"Rodgers","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0415","article-title":"Guidance on the assessment of the safety of feed additives for the consumer","volume":"15","author":"Rychen","year":"2017","journal-title":"EFSA J."},{"key":"10.1016\/j.envint.2025.109339_b0420","article-title":"The role of food chain in antimicrobial resistance spread and one health approach to reduce risks","volume":"391\u2013393","author":"Sagar","year":"2023","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.envint.2025.109339_b0425","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2885.2006.00754.x","article-title":"Critical review on the withdrawal period calculation for injection site residues","volume":"29","author":"Sanquer","year":"2006","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0430","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41597-020-0455-1","article-title":"Database of pharmacokinetic time-series data and parameters for 144 environmental chemicals","volume":"7","author":"Sayre","year":"2020","journal-title":"Science Data."},{"key":"10.1016\/j.envint.2025.109339_b0435","article-title":"Quantitative morphometric, physiological, and metabolic characteristics of chickens and mallards for physiologically based kinetic model development","volume":"13","author":"Scanes","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.envint.2025.109339_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108082","article-title":"New approach methodologies in human regulatory toxicology - Not if, but how and when!","volume":"178","author":"Schmeisser","year":"2023","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2025.109339_b0445","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tiv.2007.09.010","article-title":"General approach for the calculation of tissue to plasma partition coefficients","volume":"22","author":"Schmitt","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.envint.2025.109339_b0450","doi-asserted-by":"crossref","DOI":"10.1093\/toxres\/tfae044","article-title":"New approach methodologies (NAMs): identifying and overcoming hurdles to accelerated adoption","volume":"13","author":"Sewell","year":"2024","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.envint.2025.109339_b0455","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxlet.2024.04.013","article-title":"Physiologically based kinetic (PBK) modeling as a new approach methodology (NAM) for predicting systemic levels of gut microbial metabolites","volume":"396","author":"Stevanoska","year":"2024","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.envint.2025.109339_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106838","article-title":"Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration","volume":"200","author":"Sun","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0465","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.fct.2009.11.049","article-title":"Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humans","volume":"48","author":"Sweeney","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104691","article-title":"PBPK model reporting template for chemical risk assessment applications","volume":"115","author":"Tan","year":"2020","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.envint.2025.109339_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.112848","article-title":"A physiologically based pharmacokinetic (PBPK) model exploring the blood-milk barrier in lactating species - a case study with oxytetracycline administered to dairy cows and goats","volume":"161","author":"Tardiveau","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0480","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14573\/altex.1803011","article-title":"The US federal Tox21 program: a strategic and operational plan for continued leadership","volume":"35","author":"Thomas","year":"2018","journal-title":"ALTEX"},{"key":"10.1016\/j.envint.2025.109339_b0485","unstructured":"Thompson, C.V. 2022. Development of tools to support the application of physiologically-based kinetic modelling in safety assessment. Liverpool John Moores University (United Kingdom)."},{"key":"10.1016\/j.envint.2025.109339_b0490","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2885.2004.00604.x","article-title":"Bioavailability and its assessment","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0495","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/bcp.12234","article-title":"Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data","volume":"79","author":"Tsamandouras","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.envint.2025.109339_b0500","unstructured":"TSCA, 2016. Lautenberg Chemical Safety for the 21st Century Act. Toxic Substances Control Act, Washington, D.C., U.S. Available: https:\/\/www.congress.gov\/114\/plaws\/publ182\/PLAW-114publ182.pdf (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0505","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1124\/dmd.120.090498","article-title":"Quantification of the impact of partition coefficient prediction methods on physiologically based pharmacokinetic model output using a standardized tissue composition","volume":"48","author":"Utsey","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.envint.2025.109339_b0510","unstructured":"VICH, 2015. Studies to evaluate the metabolism and residue kinetics of veterinary drugs in food-producing animals: Marker residue depletion studies to establish product withdrawal periods (GL48). European Medicines Agency Sicence Medicines Health. Available: https:\/\/www.ema.europa.eu\/en\/vich-gl48-studies-evaluate-metabolism-residue-kinetics-veterinary-drugs-food-producing-animals-marker-residue-depletion-studies-establish-product-withdrawal-periods-scientific-guideline. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0515","unstructured":"VICH, 2019. Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI. US Food and Drug Administration. Available: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cvm-gfi-159-vich-gl36-studies-evaluate-safety-residues-veterinary-drugs-human-food-general-approach. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0520","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11095-018-2379-4","article-title":"A population WB-PBPK model of colistin and its prodrug CMS in pigs: focus on the renal distribution and excretion","volume":"35","author":"Viel","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.envint.2025.109339_b0525","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1021\/acs.jafc.2c06561","article-title":"PBPK model to predict marbofloxacin distribution in edible tissues and intestinal exposure in pigs","volume":"71","author":"Viel","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.envint.2025.109339_b0530","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1021\/acs.est.1c08068","article-title":"A generalized physiologically based kinetic model for fish for environmental risk assessment of pharmaceuticals","volume":"56","author":"Wang","year":"2022","journal-title":"Environ. Sci. Tech."},{"key":"10.1016\/j.envint.2025.109339_b0535","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/jvp.12931","article-title":"Physiological parameter values for physiologically based pharmacokinetic models in food-producing animals. Part II: Chicken and turkey","volume":"44","author":"Wang","year":"2021","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0540","unstructured":"WHO, 2005. Chemical-specific adjustment factors for interspecies differences and human variability: guidance document for use of data in dose\/concentration-response assessment. World Health Organization. Available: https:\/\/www.who.int\/publications\/i\/item\/9241546786. (accessed 16 January 2025)."},{"key":"10.1016\/j.envint.2025.109339_b0545","unstructured":"WHO, 2010. Characterization and application of physiologically based phar-macokinetic models in risk assessment. World Health Organization. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/44495\/9789241500906_eng.pdf?sequence=1. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0550","unstructured":"WHO, 2022. WHO Global Strategy for Food Safety 2022-2030. Towards Stronger Food Safety Systems and Global Cooperation. World Health Organization. Available: https:\/\/cdn.who.int\/media\/docs\/default-source\/food-safety\/public-consultation\/draft-who-global-strategy-for-food-safety-13may2021.pdf. (accessed 29 June 2024)."},{"key":"10.1016\/j.envint.2025.109339_b0555","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2885.2002.00430.x","article-title":"Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations","volume":"25","author":"Wiuff","year":"2002","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0560","doi-asserted-by":"crossref","first-page":"10639","DOI":"10.3168\/jds.2020-18760","article-title":"Population physiologically based modeling of pirlimycin milk concentrations in dairy cows","volume":"103","author":"Woodward","year":"2020","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.envint.2025.109339_b0565","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/jvp.12812","article-title":"Physiologically based modelling of the pharmacokinetics of three beta-lactam antibiotics after intra-mammary administration in dairy cows","volume":"42","author":"Woodward","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0570","doi-asserted-by":"crossref","first-page":"507","DOI":"10.46234\/ccdcw2021.131","article-title":"Food safety strategies: the one health approach to global challenges and China's actions","volume":"3","author":"Wu","year":"2021","journal-title":"China CDC Weekly."},{"key":"10.1016\/j.envint.2025.109339_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfca.2023.105437","article-title":"Determination of \u03b2-lactam antibiotics in animal derived foods by modified QuEChERS coupled with ultra performance liquid chromatography-tandem mass spectrometry","volume":"122","author":"Wu","year":"2023","journal-title":"J Food Compost Anal."},{"key":"10.1016\/j.envint.2025.109339_b0580","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/toxsci\/kfae139","article-title":"Development of a physiologically based pharmacokinetic model for flunixin in cattle and swine following dermal exposure","volume":"203","author":"Wu","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108804","article-title":"Physiologically based kinetic (PBK) modeling of propiconazole using a machine learning-enhanced read-across approach for interspecies extrapolation","volume":"189","author":"Wu","year":"2024","journal-title":"Environ. Int."},{"key":"10.1016\/j.envint.2025.109339_b0590","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1021\/acs.est.3c08314","article-title":"Fish physiologically based toxicokinetic modeling approach for in vitro\u2013in vivo and cross-species extrapolation of endocrine-disrupting chemicals in risk assessment","volume":"58","author":"Xie","year":"2024","journal-title":"Environ. Sci. Tech."},{"key":"10.1016\/j.envint.2025.109339_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111127","article-title":"A physiologically based pharmacokinetic model of doxycycline for predicting tissue residues and withdrawal intervals in grass carp (Ctenopharyngodon idella)","volume":"137","author":"Xu","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0600","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.fct.2019.02.029","article-title":"Development and application of a population physiologically based pharmacokinetic model for florfenicol and its metabolite florfenicol amine in cattle","volume":"126","author":"Yang","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0605","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/jvp.13049","article-title":"Development and application of a physiologically based pharmacokinetic model for orbifloxacin in crucian carp (Carassius auratus)","volume":"45","author":"Yang","year":"2022","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0610","article-title":"Development and application of a water temperature related physiologically based pharmacokinetic model for enrofloxacin and its metabolite ciprofloxacin in rainbow trout","volume":"7","author":"Yang","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.envint.2025.109339_b0615","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/jvp.12137.","article-title":"Estimating marbofloxacin withdrawal time in broiler chickens using a population physiologically based pharmacokinetics model","volume":"37","author":"Yang","year":"2014","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.envint.2025.109339_b0620","article-title":"Development and application of a physiologically based pharmacokinetic model for diclazuril in broiler chickens","volume":"13","author":"Yang","year":"2023","journal-title":"Animals (basel)."},{"key":"10.1016\/j.envint.2025.109339_b0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33038","article-title":"Baicalin-aluminum complex on the regulation of IPEC-1 infected with enterotoxigenic Escherichia coli","volume":"10","author":"Ye","year":"2024","journal-title":"Heliyon."},{"key":"10.1016\/j.envint.2025.109339_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113332","article-title":"A web-based interactive physiologically based pharmacokinetic (iPBPK) model for meloxicam in broiler chickens and laying hens","volume":"168","author":"Yuan","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.envint.2025.109339_b0635","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1021\/acs.jafc.7b01740","article-title":"Pharmacokinetics of mequindox and its marker residue 1,4-bisdesoxymequindox in swine following multiple oral gavage and intramuscular administration: an experimental study coupled with population physiologically based pharmacokinetic modeling","volume":"65","author":"Zeng","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.envint.2025.109339_b0640","doi-asserted-by":"crossref","first-page":"18928","DOI":"10.1021\/acs.est.4c05405","article-title":"Development of a physiologically based pharmacokinetic (PBPK) model for F-53B in pregnant mice and its extrapolation to humans","volume":"52","author":"Zhang","year":"2024","journal-title":"Environ. Sci. Tech."},{"key":"10.1016\/j.envint.2025.109339_b0645","doi-asserted-by":"crossref","unstructured":"Zhang, Z.,Tell, L.A.,Lin, Z., 2025. Comparisons of PK-Sim\u00ae and R Program for Physiologically Based Pharmacokinetic Model Development for Broiler Chickens and Laying Hens: Meloxicam as a Case Study. Toxicological Sciences, in press.","DOI":"10.1093\/toxsci\/kfaf016"},{"key":"10.1016\/j.envint.2025.109339_b0650","article-title":"Apply a physiologically based pharmacokinetic model to promote the development of enrofloxacin granules: predict withdrawal interval and toxicity dose","volume":"10","author":"Zhou","year":"2021","journal-title":"Antibiotics (Basel)."},{"key":"10.1016\/j.envint.2025.109339_b0655","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/19490976.2019.1667724","article-title":"Insights from pharmacokinetic models of host-microbiome drug metabolism","volume":"11","author":"Zimmermann-Kogadeeva","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.envint.2025.109339_b0660","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(22)01595-1","article-title":"Advancing One human-animal-environment Health for global health security: what does the evidence say?","volume":"401","author":"Zinsstag","year":"2023","journal-title":"Lancet"}],"container-title":["Environment International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016041202500090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016041202500090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:26:22Z","timestamp":1777641982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016041202500090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":132,"alternative-id":["S016041202500090X"],"URL":"https:\/\/doi.org\/10.1016\/j.envint.2025.109339","relation":{},"ISSN":["0160-4120"],"issn-type":[{"value":"0160-4120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical risk assessment in food animals via physiologically based pharmacokinetic modeling \u2212 Part I: Veterinary drugs on human food safety assessment","name":"articletitle","label":"Article Title"},{"value":"Environment International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envint.2025.109339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109339"}}